MedTrace Logo

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

NCT01018849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-01-15

No results posted yet for this study

Summary

The purpose of this study is to determine if Vitamin D supplementation helps prevent recurrent cardiovascular events, such as heart attack or stroke, in patients who have already experienced at least one cardiovascular event. This study will investigate if the addition of 150,000 international units of cholecalciferol (vitamin D3) by mouth every 2 months to a subject's medication regimen will prevent further cardiovascular events.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol

cholecalciferol 150,000 IU by mouth every 2 months for 1 year

DIETARY_SUPPLEMENT

Placebo

placebo by mouth every 2 months for 1 year

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Laura Armas, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2013-07-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01018849 on ClinicalTrials.gov